Literature DB >> 16161173

Total synthesis of (+)-batzelladine A and (-)-batzelladine D, and identification of their target protein.

Jun Shimokawa1, Takanori Ishiwata, Koji Shirai, Hiroyuki Koshino, Aya Tanatani, Tadashi Nakata, Yuichi Hashimoto, Kazuo Nagasawa.   

Abstract

Asymmetric total synthesis of batzelladine A (1) and batzelladine D (2) has been achieved. Our synthesis of batzelladines features 1) stereoselective construction of the cyclic guanidine system by means of successive 1,3-dipolar cycloaddition reaction and subsequent cyclization, 2) direct esterification of the bicyclic carboxylic acid 35 with the guanidine alcohol 8 or 59 to construct the whole carbon skeleton of batzelladines, and 3) one-step formation of the alpha,beta-unsaturated aldehyde 53 from the primary alcohol 47 with tetra-n-propylammoniumperruthenate (TPAP), providing an efficient route to the left-hand bicyclic guanidine alcohol of batzelladine A (1). With the synthetic compounds 1 and 2 in hand, their target protein was examined by using immobilized CD4 and gp120 affinity gels. The results indicated that batzelladines A (1) and D (2) bind specifically to CD4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16161173     DOI: 10.1002/chem.200500852

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  12 in total

1.  Total synthesis of (+)-batzelladine A and (-)-batzelladine D via [4 + 2]-annulation of vinyl carbodiimides with N-alkyl imines.

Authors:  Michael A Arnold; Kenneth A Day; Sergio G Durón; David Y Gin
Journal:  J Am Chem Soc       Date:  2006-10-11       Impact factor: 15.419

2.  Syntheses of Cyclic Guanidine-Containing Natural Products.

Authors:  Yuyong Ma; Saptarshi De; Chuo Chen
Journal:  Tetrahedron       Date:  2015-02-25       Impact factor: 2.457

3.  Recent Developments in Pd(0)-Catalyzed Alkene Carboheterofunctionalization Reactions.

Authors:  Zachary J Garlets; Derick R White; John P Wolfe
Journal:  Asian J Org Chem       Date:  2017-03-10       Impact factor: 3.319

4.  A convergent approach to batzelladine alkaloids. Total syntheses of (+)-batzelladine E, (-)-dehydrobatzelladine C, and (+)-batzelladine K.

Authors:  Christos Economou; Justin P Romaire; Tony Z Scott; Brendan T Parr; Seth B Herzon
Journal:  Tetrahedron       Date:  2018-04-18       Impact factor: 2.457

5.  A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products.

Authors:  Christopher E Malmberg; Stephen Chamberland
Journal:  J Vis Exp       Date:  2016-09-09       Impact factor: 1.355

6.  Concise Synthesis and Antimicrobial Evaluation of the Guanidinium Alkaloid Batzelladine D: Development of a Stereodivergent Strategy.

Authors:  You-Chen Lin; Aubert Ribaucourt; Yasamin Moazami; Joshua G Pierce
Journal:  J Am Chem Soc       Date:  2020-05-12       Impact factor: 15.419

7.  Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.

Authors:  M Alejandro Valdes-Pena; Nicholas P Massaro; You-Chen Lin; Joshua G Pierce
Journal:  Acc Chem Res       Date:  2021-03-18       Impact factor: 22.384

Review 8.  Batzella, Crambe and Monanchora: Highly Prolific Marine Sponge Genera Yielding Compounds with Potential Applications for Cancer and Other Therapeutic Areas.

Authors:  Amr El-Demerdash; Atanas G Atanasov; Anupam Bishayee; Mamdouh Abdel-Mogib; John N A Hooper; Ali Al-Mourabit
Journal:  Nutrients       Date:  2018-01-02       Impact factor: 5.717

9.  Stereocontrolled synthesis of bicyclic sulfamides via Pd-catalyzed alkene carboamination reactions. Control of 1,3-asymmetric induction by manipulating mechanistic pathways.

Authors:  Nicholas R Babij; Grace M McKenna; Ryan M Fornwald; John P Wolfe
Journal:  Org Lett       Date:  2014-06-11       Impact factor: 6.005

Review 10.  Polycyclic Guanidine Alkaloids from Poecilosclerida Marine Sponges.

Authors:  Estelle Sfecci; Thierry Lacour; Philippe Amade; Mohamed Mehiri
Journal:  Mar Drugs       Date:  2016-04-09       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.